Document is current
Any future updates will be listed below
-
Authors
Schiener, Maximilian
Hilger, Christiane https://orcid.org/0000-0001-9455-5442
Eberlein, Bernadette
Pascal, Mariona
Kuehn, Annette
Revets, Dominique
Planchon, Sébastien
Pietsch, Gunilla
Serrano, Pilar
Moreno-Aguilar, Carmen
de la Roca, Federico
Biedermann, Tilo
Darsow, Ulf
Schmidt-Weber, Carsten B.
Ollert, Markus
Blank, Simon
- License Information
-
More Information
Article History
Received: 4 September 2017
Accepted: 4 January 2018
First Online: 22 January 2018
Competing Interests
: MS has received travel support from ALK-Abelló and Bencard. BE has received research funding from Bühlmann Laboratories. UD has been speaker, investigator and /or been a member of advisory boards for Allergopharma, ALK-Abelló, Bencard, GSK, Hermal, MEDA, Novartis Pharma, Stallergenes, Stiefel. TB has received research funding, speaker’s honorarium and consultancy fees from Thermo Fisher Scientific, has received research support from DFG, Novartis and Thermo Fisher Scientific, has received lecture fees from MSD, Novartis, HIPP GmbH & Co, ALK-Abelló, MedComms Ltd and Astellas Pharma GmbH. CBS-W has received grants from Allergopharma, Leti, PLS-Design and Regeneron; is member of the scientific advisory board of Leti and Bencard; has received consultancy fees from Leti, GLG Consultancy, Allergopharma and Bencard. MO has received consultancy fees from Siemens Healthcare, Hitachi Chemical Diagnostics and Bencard; has received lecture fees from Thermo Fisher Scientific, Bencard and Siemens Healthcare; is co-founder of PLS-Design GmbH. SB has received speaker’s honorarium and/or travel support from ALK-Abelló, Bencard and Thermo Fisher Scientific; has received consultancy fees as an advisory board member and research support from Bencard and Allergy Therapeutics. The other authors declare that they have no conflict of interest.
